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CRM1 Is an Export Receptor for Leucine-Rich
Nuclear Export Signals
Maarten Fornerod,*³ Mutsuhito Ohno,*³ subunit of importin (Pollard et al., 1996; Nakielny et al.,
1996; Fridell et al., 1997). M9 also functions as a signalMinoru Yoshida,² and Iain W. Mattaj*§
for nuclear export in mammalian cells (Michael et al.,*European Molecular Biology Laboratory
1995). Recognition of parts of the hnRNP A1 proteinD-69117 Heidelberg
including, but not confined to, the M9 domain, is re-Germany
quired for export of some mRNAs (Izaurralde et al.,²Department of Biotechnology
1997), but it is not yet known whether transportin playsUniversity of Tokyo
a role in hnRNP A1 or mRNA export. The likely yeastTokyo 113
homolog, transportin or Kap104p (Aitchison et al., 1996;Japan
Nakielny et al., 1996), has also been implicated in the
nuclear import of hnRNP-like proteins (Aitchison et al.,
1996). Two additional yeast importin b relatives, Kap123pSummary
and Pse1, have recently been proposed to be mediators
of ribosomal protein import (Rout et al., 1997).CRM1 is distantly related to receptors that mediate
There are other characterized protein import signalsnuclear protein import and was previously shown to
(e.g., Mandell and Feldherr, 1990; Kambach and Mattaj,interact with the nuclear pore complex. Overexpres-
1992; Michael et al., 1997) that do not obviously resem-sion of CRM1 in Xenopus oocytes stimulates Rev and
ble either M9 or an NLS and whose import is likely toU snRNA export from the nucleus. Conversely, lepto-
involve additional ªreceptors.º In addition, a corre-mycin B, a cytotoxin that is shown to bind to CRM1
sponding variety of nuclear export substrates existsprotein, specifically inhibits the nuclear export of Rev
(Jarmolowski et al., 1994; Fischer et al., 1995; Michaeland U snRNAs. In vitro, CRM1 forms a leptomycin
et al., 1995; Pokrywka and Goldfarb 1995; Wen et al.,B±sensitive complex involving cooperative binding of
1995). In analogy to import, nuclear export is alsoboth RanGTP and the nuclear export signal (NES) from
thought to be mediated by signals. So far, the besteither the Rev or PKI proteins. We conclude that CRM1
defined nuclear export signals (NESs) are a family ofis an export receptor for leucine-rich nuclear export
leucine-rich peptide NESs first identified in the HIV-1signals and discuss a model for the role of RanGTP
Rev protein and in the cellular protein kinase A inhibitorin CRM1 function and in nuclear export in general.
PKI (Fischer et al., 1995; Wen et al., 1995). Saturation
of the leucine-rich peptide NES pathway specifically in-
Introduction hibits the export of this class of proteins and of U
snRNAs and 5S rRNA (Fischer et al., 1995), a result that
The fact that RNA and protein synthesis occur in sepa- suggests that these classes of export substrate may
rate compartments of eukaryotic cells creates a require- share a common export receptor.
ment for a very high level of macromolecular trafficking The energy dependence of nucleocytoplasmic trans-
between the nucleus and cytoplasm. For most protein port is explained at least in part by the requirement for
and all known RNA transport substrates, transport into the small GTPase Ran for all forms of active import and
or out of the nucleus is a saturable, energy-dependent, export thus far studied (Melchior et al., 1993; Moore
and thus ªreceptorº-mediated process. The saturability and Blobel, 1993; Chi et al., 1996; GoÈ rlich et al., 1996a;
reflects the presence of signals for transport on protein Palacios et al., 1996; Sweet and Gerace, 1996; Weis et
or RNA substrates that are recognized by transport me- al., 1996; E. Izaurralde et al., submitted; Richards et al.,
diators whose concentration can become limiting in the 1997). In addition, the components of the Ran GTPase
presence of excess substrate (Zasloff, 1983; Goldfarb system, that is, the nucleotide exchange factor RCC1/
et al., 1986; Hamm and Mattaj, 1990; Jarmolowski et al., Prp20p, the GTPase activating protein RanGAP1/
1994; Fischer et al., 1995). Rna1p, and the Ran binding protein RanBP1/Yrb1p, are
Transport signals for nuclear protein import have been arranged asymmetrically such as to produce a high Ran
well characterized. One group of sequences form the GTP:Ran GDP ratio in the nucleus and the reverse ratio
basic nuclear localization signal (NLS) family (reviewed in the cytoplasm (reviewed by Moore and Blobel, 1994;
by Dingwall and Laskey, 1991). These interact with the GoÈ rlich and Mattaj, 1996; Koepp and Silver, 1996; Nigg,
a subunit of importin, the ªNLS receptor.º Importin is a 1997). This asymmetric distribution of RanGTP has re-
heterodimer with an a and a b subunit that was charac- cently been shown to be a requirement not only for NLS
terized in several laboratories in parallel (for reviews, protein import (GoÈ rlich et al., 1996a) but also for the
see Powers and Forbes, 1994; GoÈ rlich and Mattaj, 1996; export of NES proteins (Richards et al., 1997) and for
Nigg, 1997). A second import signal is the M9 domain the export and import of a large variety of other transport
found in hnRNP A1 and a family of related hnRNP pro- substrates (E. Izaurralde et al., submitted).
teins (Michael et al., 1995; Siomi and Dreyfuss, 1995; The likely reason for this is illustrated by considering
Weighardt et al., 1995). The receptor that mediates M9 examples. RanGTP binding to importin b dissociates it
import into the nucleus, transportin, is related to the b from importin a (Rexach and Blobel, 1995; Chi et al.,
1996; GoÈ rlich et al., 1996a). Thus, RanGTP disassembles
the NLS import receptor complex, a reaction that termi-³These authors contributed equally to this work.
§To whom correspondence should be addressed. nates NLS protein import (GoÈ rlich et al., 1996a; Kutay
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et al., 1997). Similarly, RanGTP dissociates transportin
from theM9 signal (E. Izaurralde et al., submitted). These
interactions are thought to occur in the nucleus and
ensure that import substrate:import receptor interaction
cannot stably occur there, that is, RanGTP-induced dis-
sociation of the import receptor-substrate complexes
prevents reexport by reversal of the import reaction. The
same RanGTP±importin b interaction also plays a role
in imparting directionality to U snRNA export (GoÈ rlich
et al., 1996b) although in a more complex way. Possible
predictions from these studies are that interactions be-
tween export receptors and their substrates might be
dissociated by interaction with RanGDP when they
reach the cytoplasm or, alternatively, formation of com-
plexes between export receptors and their cargo might
be dependent upon RanGTP.
One can predict that export receptors will bind not
only their substrate and Ran but also, like importin b or
transportin, interact with nucleoporins, proteins of the
nuclear pore complex (NPC). Although this would not
necessarily involve the same NPC proteins for each
transport mediator, reagents that prevent access to
nucleoporins block many nuclear import and export
pathways (e.g., Finlay et al., 1987; Powers et al., 1997).
Also, an importin b mutant that cannot be dislodged
from certain NPC sites (GoÈ rlich et al., 1996a) is a domi-
nant negative inhibitor of all tested forms of active
nucleocytoplasmic transport (Kutay et al., 1997). An ex-
tensive family of proteins that resemble importin b has
recently been identified (Fornerod et al., 1997; GoÈ rlich
et al., 1997) and proposed to consist of transport factors
based on twoarguments. First, the similarity of the family
members is greatest near their N termini. This region of Figure 1. Leptomycin B Specifically Inhibits Rev Protein and U
importin b is required for Ran binding, and several family snRNA Export in Xenopus Oocytes
members bind Ran in vitro (GoÈ rlich et al., 1997). Second, (A) Xenopus laevis oocytes were incubated for 2 hr in the absence
(lanes 1±9) or presence (10 nM, lanes 10±15; 100 nM, lanes 16±21)one of the family, human CRM1, interacts directly with
of leptomycin B. Subsequently 35S-labeled HIV-1 Rev and importinthe nucleoporin CAN/Nup214 (Fornerod et al., 1996,
a (a) proteins were injected into the nucleus and incubation was1997).
continued in the same media. Protein samples from total oocytes
CRM1 was first identified in the fission yeast, Schizo- (T) or from cytoplasmic (C) or nuclear (N) fractions were collected
saccharomyces pombe, where its mutation causes ab- immediately (lanes 1±3), 90 min (lanes 4±6, 10±12, and 16±18) or 180
normal chromosome morphology (Adachi and Yana- min (lanes 7±9, 13±15 and 19±21) after injection and analyzed by
SDS-PAGE.gida, 1989). S. pombe CRM1 is the target of a cytotoxin,
(B) Oocytes were incubated in the absence (lanes 1±6) or presenceleptomycin B, and mutations in CRM1 can render S.
of leptomycin B (100 nM; lanes 7±9) as in A. 35S-labeled CBP80 andpombe resistant to its effects (Hamamoto et al., 1983;
hnRNP A1 proteins were then injected into the cytoplasm. Protein
Nishi et al., 1994). In mammalian cells, leptomycin B samples were collected immediately (lanes 1±3) or 5 hr (lanes 4±9)
blocks both HIV-1 Rev-dependent pre-mRNA export after injection.
from the nucleus and the actinomycin D±dependent (C) Xenopus oocytes were incubated with leptomycin B as in (A),
then injected into the nucleus with a mixture of 32P-labeled RNAsrelocation of Rev protein from the nucleus to the cyto-
containing: DHFR mRNA,U1DSm, U5DSm, U6Dss, and human initia-plasm (Wolff et al., 1997), suggesting that either the
tor methionyl tRNA. RNA was extracted immediately (lanes 1±3), 20viral Rev protein itself or a cellular factor required for
min (lanes 4±6, 10±12, and 16±18), or 180 min (lanes 7±9, 13±15,
Rev export from the nucleus might be a target for lepto- and 19±21) after injection.
mycin B.
Here we show that leptomycin B inhibits the nuclear
Resultsexport of both Rev and U snRNAs, suggesting that the
cellular target of leptomycin B is involved in their export.
Leptomycin B Is a Specific Inhibitor of RevAn in vitro interaction between leptomycin B and both
and U snRNA Exporthuman and S. pombe CRM1 is demonstrated. Moreover,
To determine whether leptomycin B would affect theexpression of human CRM1 in Xenopus oocytes is
import or export of cellular factors, the transport of vari-shown to increase the rate of Rev and U snRNA nuclear
ous substrates was analyzed in Xenopus laevis oocytes.export and to reverse leptomycin B±induced inhibition
The kinetics of export of 35S-labeled Rev protein afterof Rev export. In vitro, CRM1 binds in a cooperative way
its microinjection into the nucleus is shown in Figure 1Ato both RanGTP and either Rev or PKI NES peptides.
Thus, CRM1 is an export receptor for leucine-rich NESs. (lanes 1±9), where T designates extract of total oocytes
CRM1 and Nuclear Export
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and C and N cytoplasmic and nuclear fractions. Incuba-
tion of the oocytes in 10 nM leptomycin B reduced Rev
export (lanes 10±15) and 100 nM leptomycin B essen-
tially blocked export (lanes 16±21). Neither the import
of an NLS-containing protein (CBP80; Izaurralde et al.,
1995a) nor that of the M9-containing hnRNP A1 (Figure
1B, compare lanes 4±6 with lanes 7±9) was detectably
affected by leptomycin B at 100 nM. Similarly, lepto-
mycin B had no detectable effect on the export from
the nucleus of either importin a or transportin (Figures
1A and 4).
The effect of leptomycin B on the nuclear export of
RNA substrates was also tested. A mixture of RNAs
including dihydrofolate reductase mRNA, two U snRNAs,
U1DSm and U5DSm, initiator methionyl tRNA, and U6
Dss RNA, was microinjected into oocyte nuclei. U6 RNA
remains in the nucleus as a marker of injection accuracy
and nuclear integrity. Because the RNAs are exported
with very different kinetics (Jarmolowski et al., 1994),
their export was examined after 20 and 180 min. Control
oocytes (Figure 1C, lanes 1±9) showed rapid export of
tRNA and slower export of the mRNA and U snRNAs.
Incubation of the oocytes in either 10 or 100 nM lepto-
mycin B did not affect mRNA or tRNA export detectably
(Figure 1C, lanes 10±21) but reduced (10 nM) or blocked
Figure 2. Effect of Leptomycin B on CRM1 Proteins(100 nM) U1 and U5 snRNA export. These data are remi-
(A) 35S-labeled human (H. sap.), S. cerevisiae (S. cer.), and S. pombeniscent of the block of export of Rev and U snRNAs by
CRM1 proteins were incubated alone (lanes 1, 6, and 11) or with
saturating levels of NES peptides (Fischer et al., 1995) 50, 100, 200, or 400 nM leptomycin B for 45 min at 308C, then
and strongly suggest that the cellular target of lepto- analyzed by nondenaturing polyacrylamide gel electrophoresis.
mycin B is involved in both Rev and U snRNA export. (B) Xenopus oocytes were incubated with leptomycin B, then a
mixture of 35S-labeled hCRM1 and CBP80 proteins was injected into
the cytoplasm (lanes 1±6) or the nucleus (lanes 7±12). Protein was
extracted from cytoplasmic (C) and nuclear (N) fractions immediatelyLeptomycin B Interacts with CRM1
(lanes 1, 2, 7, and 8) or 6 hr (lanes 3±6 and 9±12) after injection.Since CRM1 is the leptomycin B target in S. pombe
(see Introduction), interaction of leptomycin B with 35S-
labeled CRM1 protein from human, S. pombe, and Sac-
the nucleus (Figure 2B, lanes 7±10). The distribution ofcharomyces cerevisiae was assayed. The three CRM1
CRM1 seen in lanes 3, 4, 9, and 10 therefore representsproteins were separated on native polyacrylamide gels
the steady state of its shuttling between the nucleuseither alone (Figure 2A, lanes 1, 6, and 11) or in the
and cytoplasm. Leptomycin B had no detectable effectpresence of leptomycin B. Leptomycin B did not affect
on export of CRM1 (Figure 2B, lanes 11 and 12) and atthe mobility of the S. cerevisiae protein (lanes 7±10), but
most a minor effect on its import (lanes 5 and 6).both the human and S. pombe proteins have a higher
mobility in the presence of leptomycin B, suggesting
that both proteins change conformation on binding lep- hCRM1 Expression in Oocytes Increases
Rev and U snRNA Exporttomycin B. Direct binding between CRM1 and lepto-
mycin B was confirmed by repeating the experiment The effects of leptomycin B on nuclear export and its
binding to CRM1 suggest that CRM1 might have a roleusing recombinant human CRM1 protein made in an E.
coli extract with the identical result (data not shown; in Rev and U snRNA export. This was analyzed by (over)-
expressing human CRM1 (hCRM1) in Xenopus oocytessee Figure 5C). The apparent lack of binding to the S.
cerevisiae CRM1 protein may explain why this yeast and by measuring the rate of export of these substrates.
hCRM1 mRNA was microinjected into the cytoplasmspecies is insensitive to leptomycin B (Hamamoto et al.,
1983). of Xenopus oocytes. One day later, expressed hCRM1
protein was readily detected by Western blot using anti-Since leptomycin B affects nuclear export, and since
CRM1 distantly resembles importin b, we wished to test hCRM1 antibodies (Fornerod et al., 1997), although we
cannot accurately estimate the level of overexpressionwhether CRM1 protein, like importin b, would move be-
tween the nucleus and cytoplasm and whether lepto- since we do not know whether the CRM1 antibody rec-
ognizes the endogenous Xenopus protein and humanmycin B would affect its transport. 35S-labeled human
CRM1 protein was injected into either the cytoplasm CRM1 identically.
The mixture of RNA export substrates was injected(Figure 2B, lanes 1±6) or the nucleus (lanes 7±12) of
Xenopus oocytes, together with CBP80 as an internal into the nucleus at this time (Figure 3A, lanes 1±3). RNA
export was assessed 150 min later in oocytes prein-control. CRM1 was imported into the nucleus from the
cytoplasm (Figure 2B, lanes 1±4). Unlike CBP80, CRM1 jected into the cytoplasm with hCRM1 mRNA. This had
no effect on mRNA or tRNA export, but the export of bothwas also detected in the cytoplasm after injection into
Cell
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Figure 4. hCRM1 Accelerates Rev Export and Reverses the Inhibi-
tory Effect of Leptomycin B
Either water (lanes 1±6 and 10±12) or hCRM1 mRNA (lanes 7±9 and
13±15) was injected into the cytoplasm of Xenopus oocytes. After
23 hr the oocytes were placed in control medium (lanes 1±9) or
leptomycin B (40 nM, lanes 10±15). After 2 hr 35S-labeled Rev and
transportin (TRN) proteins were injected into the nucleus. Proteins
were extracted immediately (lanes 1±3) or 65 min (lanes 4±15) after
injection.
in 40 nM leptomycin B (Figure 4, lanes 10±12). This
inhibitory effect was completely reversed in the oocytes
that had been preinjected with hCRM1 mRNA (lanes
13±15). Transportin was coinjected with Rev as an inter-
nal control. Its export was not affected by any of the
treatments (Figure 4). Thus, increasing the concentra-
tion of CRM1 in Xenopus oocytes by supplementing
the endogenous protein with exogenously expressed
human CRM1 stimulates the rate of export of both U
snRNAs and Rev protein, and the inhibitory effect of
leptomycin B on Rev export was reversed by hCRM1.
This is direct evidence of a role for CRM1 in U snRNAFigure 3. hCRM1 Specifically Accelerates U snRNA Export in Xeno-
and Rev export.pus Oocytes
(A) Unlabeled DHFR mRNA (lanes 1±6) or hCRM1 mRNA (lanes 7±9)
was injected into the cytoplasm of Xenopus oocytes. After 24 hr, a Cooperative Interactions Involving hCRM1,
mixture of 32P-labeled RNAs was injected into the nucleus. RNA RanGTP, and NES Peptides
was extracted immediately (lanes 1±3) or 150 min (lanes 4±9) after
The above data stongly implicate CRM1 in NES proteininjection.
export. If CRM1 is the ªNES receptorº it should interact(B) The percentage of U1 and U5 snRNA in the cytoplasmic (C) and
with NES peptides directly, perhaps (see Introduction)nuclear (N) fractions of control oocytes or hCRM1 mRNA-injected
oocytes was determined by phosphoimager analysis. Control oo- in a RanGTP-dependent way. To investigate binding of
cytes were preinjected with H2O. The error bars represent the maxi- Ran and NES peptides to CRM1, we made use of a
mum and minimum values obtained from two separate experiments, RanQ69L IgG-binding domain fusion protein (the gift of
both independent of that shown in (A).
D. GoÈ rlich). RanQ69L is incapable of GTP hydrolysis
(Bischoff et al., 1994; Klebe et al., 1995). This protein
was immobilized on IgG-Sepharose beads. 35S-labeledU1 and U5 snRNAs was increased in hCRM1-injected
oocytes (Figure 3A, lanes 4±9). In control oocytes, CRM1 protein made in reticulocyte lysate was incubated
with the beads, but, unlike importin b (Figure 5A, lanesroughly two-thirds of the two U snRNAs was still nuclear,
while in oocytes injected with hCRM1 mRNA the nuclear 15 and 16), did not bind immobilized RanQ69LGTP and
remained in the supernatant (Figure 5A, lanes 1 and 2).fraction was approximately one-third. The result of two
additional independent experiments is summarized in In the presence of increasing concentrations of wild-
type Rev NES peptide (CLPPLERLTR; Malim et al., 1989,Figure 3B. Preinjection of hCRM1 mRNA reproducibly
stimulated the rate of export of both U1 and U5 snRNAs. 1991; Fischer et al., 1995), however, a greater and
greater fraction of CRM1 bound to the RanQ69L columnPreinjection of mRNAs encoding either importin b or
transportin had no effect on RNA export (data not (Figure 5A, lanes 3±10). M10 mutant NES peptide
(CLPPDLRLTR; Malim et al., 1989) did not allow efficientshown).
An analogous experiment with Rev was carried out. binding of CRM1 to RanGTP (Figure 5B, lanes 1±6). A
second protein with an NES is the protein kinase AThe incubation time (65 min) was chosen such that only
60% of the microinjected Rev protein was exported (Fig- inhibitor PKI (Wen et al., 1995). We therefore tested
whether a PKI NES peptide (CELALKLAGLDIN) wouldure 4, lanes 1±6). Rev export was not affected by control
cytoplasmic preinjection (Figure 4, lanes 4±6) but was also promote complex assembly on RanGTP. The wild-
type PKI peptide caused CRM1 binding (Figure 5B, lanesstimulated to 95% by the preinjection of hCRM1 mRNA
(lanes 7±9). At this time point, Rev export was signifi- 7 and 8), while three inactive mutant versions that
change two (P10) or one (P12, P13) amino acid in thecantly inhibited when control oocytes were incubated
CRM1 and Nuclear Export
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Figure 6. Complexes Containing CRM1
35S-labeled hCRM1 protein was incubated as indicated above the
lanes in the presence or absence of 200 mM NES peptide (NES),
M10 mutant peptide (M10), 1 mg of BSA-NES orBSA-M10 conjugate,
1.6 mM RanQ69LGTP (Q69L), RanT24NGDP (T24N), and/or 400 nM
leptomycin B (LMB). Proteins were subsequently cross-linked with
0.02% glutaraldehyde (lanes 2±7 and 9±13). Positions of hCRM1
and complexes I, II, and III as well as of molecular weight markers
are indicated.
Figure 5. Interaction of hCRM1 with Immobilized RanQ69LGTP in
the Presence of NES Peptide
(A) 35S-labeled rabbit reticulocyte-derived CRM1 (lanes 1±14) or im- formation. To rule this out, we made hCRM1 by transla-
portin-b (lanes 15±16) was incubated with RanQ69LGTP beads in tion inan E. coli±derived lysate.Again, binding of hCRM1
the absence (lanes 1±2 and 15±16) or presence of Rev NES peptide to RanQ69L was seen only in the presence of wild-typeat 1 mM (lanes 3±4), 10 mM (lanes 5±6), 100 mM (lanes 7±8) or 1 mM
NES peptide (Figure 5C, lanes 1±6) and was abolished(lanes 9±10). Separate reactions with the highest concentration NES
by leptomycin B (lanes 7 and 8).peptide were supplemented with 400 nM leptomycin B (lanes 11±12)
or SDS (lanes 13±14). Samples were subsequently fractionated into To further establish that the NES is part of the
supernatant (S) and bound pellet (P) fractions, and analyzed by SDS- RanGTP-CRM1 complex, a cross-linking approach was
PAGE. used. CRM1 produced in reticulocyte lysate was em-
(B) A comparison of wild-type (wt) and mutant versions of either the
ployed because the many incomplete translation prod-Rev NES peptide (lanes 3±6) or the PKI NES peptide (lanes 7±14)
ucts in the bacterially produced protein (Figure 5C) gaveon the interaction of hCRM1 with RanQ69LGTP. Reactions were
rise to a smear of products in cross-linking experiments.performed as in A and contained no peptide (lanes 1 and 2) or 100
mM of Rev NES peptide (lanes 3 and 4), M10 mutant Rev NES peptide Glutaraldehyde treatment of CRM1 protein in the pres-
(lanes 5 and 6), PKI NES peptide (lanes 7 and 8), and three inactive ence of RanQ69L or Rev NES peptide did not affect its
mutants thereof (P10, P12, and P13, respectively, lanes 9±14). mobility (Figure 6, lanes 1±3). However, two new com-
(C) E. coli lysate-derived 35S-labeled hCRM1 was incubated with plexes (I and II) were seen when both RanQ69LGTP and
RanQ69LGTP beads in the absence (lanes 1±2) or presence of 200
Rev NES peptide were added simultaneously (lane 4).mM PKI NES (lanes 3±4 and 7±8) or PKI P10 mutant (lanes 5±6)
These complexes contain Ran, as they can be affinity-peptide, and in the absence or presence (lanes 7±8) of 400 nM
leptomycin B (LMB), and analyzed as in (A). selected onNTA-nickel resin when Histidine-taggedRan
is used (data not shown), but may also contain other
components (see Discussion). Their formation depends
on wild-type NES peptide (lane 6), is inhibited by lepto-peptide (Wen et al., 1995) did not (Figure 5B, lanes 9±14).
Finally, leptomycin B inhibited CRM1-RanQ69L interac- mycin B (lane 7), and does not occur when RanT24NGDP
(Klebe et al., 1995), that cannot stably form the GTP-tion even in the presence of the highest concentration
of NES peptide (Figure 5A, lanes 11 and 12). Leptomycin bound state, is substituted for RanQ69LGTP (lane 5).
Thus, like the RanGTP-CRM1-NES peptide interactionsB is a lipophilic molecule with several polar groups,
somewhat resembling a weak detergent. However, no described in Figure 5, formation of the cross-linked com-
plexes involves cooperative binding.inhibitory effect on CRM1 binding was seen when the
same concentration of SDS or of Triton X-100 was used The small size of the NES peptides in relation to com-
plexes I and II, and the unlikelihood that such small(Figure 5A, lanes 13 and 14, and data not shown). These
binding studies showed that CRM1 binds to RanGTP in targets would be efficiently cross-linked to CRM1, pre-
vents the definitive conclusion that the NES is part ofa wild-type NES±dependent way but used CRM1 protein
made in reticulocyte lysate, making it possible that other complexes I and II. We therefore repeated the cross-
linking experiment making use of BSA-NES or BSA-M10components of the lysate were required for complex
Cell
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peptide conjugates, whose apparent size is 70±80 kDa
(data not shown). In the simultaneous presence of the
wild-type NES conjugate and of RanQ69LGTP, we now
see a new complex whose apparent molecular weight
is 70 kDa larger than complex II (complex III, Figure 6,
lanes 8±11). Formation of complex III is only seen with
the wild-type NES conjugate (lanes 11 and 12) and is
inhibited by leptomycin B (lane 13). If larger BSA conju-
gates containing more peptides are used in a cross-
linking experiment, the correspondingcomplex III is also
larger (data not shown). In conclusion, the results in this
section show that CRM1 binds directly to both NES
peptide and to RanGTP in a cooperative way.
Discussion
Figure 7. A Model for Directional Nucleocytoplasmic Transport
Import or export of receptor-cargo complexes through nuclear pore
The data presented suggest that CRM1 is a nuclear complexes (center of each panel) is shown schematically. Although
export receptor for both U snRNAs and proteins like we show both receptors and cargosas single entities, as exemplified
Rev that carry a leucine-rich NES. First, leptomycin B, by the import complex consisting of transportin and hnRNP A1,
both the receptor and the cargo can be di- or oligomeric. RanGTPa cytotoxin that we show interacts with human or S.
binding to an import receptor through the conserved Ran bindingpombe CRM1, inhibits both Rev and U snRNA export.
domain dissociates the cargo-receptor complex in the nucleus.Second, expression of human CRM1 in Xenopus oo-
Conversely, RanGTP binding to the same domain of export recep-cytes leads to an increase in the rate of Rev and U snRNA
tors (exportins) enables cargo-receptor interaction in the nucleus.
export and can reverse the export inhibition induced by Note that it is not yet known whether an intact RanGTP-receptor-
leptomycin B. Third, CRM1 forms a complex in vitro that cargo export complex would ever leave the NPC intact. It is possible
that Ran and/or cargo dissociation could occur on the NPC.contains RanGTP and the NES and is dependent on
both of these for its formation. Complex formation is
inhibited by leptomycin B.
and can form a stable complex that contains both Ran
Earlier work had revealed that CRM1 is distantly re-
and Ran-bound RanBP1 (Chi et al., 1996; GoÈ rlich et al.,
lated to nuclear protein import receptors like importin 1996a; Kutay et al., 1997; Lounsbury and Macara, 1997).
b and transportin (Fornerod et al., 1997; GoÈ rlich et al., Further work is required to characterize complex II.
1997), and that, similar to those molecules, it is located Leptomycin B inhibits the formation of the complex
in part at nuclear pore complexes (NPCs) and in part in that contains the NES, RanGTP and CRM1. Since both
soluble form, in the case of CRM1 in the nucleoplasm ligands are required to stably form this complex, their
(Adachi and Yanagida, 1989; Fornerod et al., 1997). At
binding to CRM1 must involve cooperativity. There is
least one nucleoporin with which CRM1 interacts has
no evidence that the NES can directly interact with Ran.
been identified, CAN/Nup214, and this association ap-
We therefore consider it likely that RanGTP and the NES
pears to be a dynamic one (Fornerod et al., 1996, 1997).
peptide bind to distinct sites on CRM1 and cause a
The role of this interaction in export will be an interesting
conformational change that stabilizes the complex (as
area of future study.
illustrated schematically in Figure 7). Leptomycin B
could therefore act in several ways to prevent complex
formation. It could inhibit either RanGTP binding, inhibitAssociation of CRM1 and Export Substrate
CRM1 forms a complex that is shown by a combination NES binding, or prevent the change in conformation
necessary to stabilize the CRM1-export cargo complex.of cross-linking and affinity purification to include both
the NES-containing substrate and RanGTP. The cross- CRM1 also acts in U snRNA export. This process is
inhibited by injection of saturating levels of NES peptidelinked complexes (I and II), formed in the presence of a
1.2 kDa Rev NES peptide and whose apparent molecular conjugate (Fischer et al., 1995),suggesting the existence
of a mediator of U snRNA export that has a Rev-likeweight would thus be little affected by the substrate,
are 28 and 52 kDa larger than CRM1. Since Ran has an NES. The only U snRNA-associated proteins known to
be involved in export from the nucleus are CBP80 andapparent molecular weight close to 28 kDa and is also
shown to bind CRM1, the smaller complex is likely to CBP20, the components of the nuclear cap-binding
complex (CBC; Izaurralde et al., 1994, 1995b). At pres-contain CRM1 and Ran. Its formation also requires NES
peptide, which is likely to be an integral component as ent, it is unclear whether CBC might form a complex
directly with CRM1 or whether other proteins are in-shown by the fact that NES peptides are readily cross-
linked to the complex when conjugated to BSA. volved that form bridging interactions between CBC and
CRM1. It is possible that the interacting protein in thisIt is less certain what, in addition to Ran and CRM1,
gives rise to complex II. Reasonable possibilities are case could be identified using the RanQ69LGTP-binding
assay (Figure 5). Indeed, this could potentially be a gen-that it is complex I plus either a second Ran molecule
or Ran BP1 from the reticulocyte lysate. Although Ran eral assay for active NES sequences.
usually behaves as a monomer, it was shown to interact
with itself in a two-hybrid assay (Dingwall et al., 1995). CRM1 or Rip/Rab or Both as the NES Receptor
Previous studies, mainly using the two-hybrid assay,RanBP1 is a candidate as importin b, which interacts
with Ran through a domain similar to that found in CRM1 have suggested that the Rev NES binds specifically to
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the yeast Rip protein or to the related human Rip/Rab As described in the introduction, the components of
the Ran system (RanGAP1, RanBP1, and RCC1) areprotein (Bogerd et al., 1995; Fritz et al., 1995; Stutz et
al., 1995). These studies also provided evidence of a organized within the cell in a way that predicts the exis-
tence of a steep RanGTP concentration gradient acrossrole for Rip/Rab in Rev-mediated pre-mRNA export. The
two-hybrid interactions with Rip/Rab are specific for the nuclear pore complex. The significance of this distri-
bution relates to the effect of RanGTP on complexesproteins containing an active NES, and a good correla-
tion exists between the activity of a protein in export between transport cargo and either import or export
receptors, as summarized schematically in Figure 7.and its strength of interaction with either yeast or human
Rip in this assay (Bogerd et al., 1995; Fritz et al., 1995; Import receptors, like importin b and transportin, are
separated from their cargos by interaction with RanGTPStutz et al., 1995). One group has also reported interac-
tion between a GST-Rev fusion protein and human Rab (Rexach and Blobel, 1995; Chi et al., 1996; GoÈ rlich et
al., 1996a; E. Izaurralde et al., submitted). As noted pre-produced in reticulocyte lysate (Bogerd et al., 1995).
The Rip proteins resemble a family of nucleoporins viously (GoÈ rlich and Mattaj, 1996; GoÈ rlich et al., 1996a,
1996b), interaction between RanGTP and importin b oc-that contain irregular repeats ending in FG dipeptides
(Doye and Hurt, 1997). Several of these proteins, includ- curring in the nucleus, but not in the cytoplasm, would
provide asymmetry across the nuclear envelope in im-ing the vertebrate CAN/Nup214, contain FG repeats that
produce positive results with the Rev NES in the two- port complex formation and dissociation (Figure 7) and
thus impart directionality to the import process. In thehybrid interaction assay (Fritz and Green, 1996; Stutz et
al., 1996). The functional relevance of interaction with case of transportin, the cargo is an M9-containing pro-
tein, whereas here we define the importin b cargo asthese repeats is supported by the observation that mi-
croinjection of some repeat-containing nucleoporin the importin a-NLS protein complex. Note that this is
not the only function of RanGTP in import. RanGTP bind-fragments into Xenopus oocyte nuclei inhibits nuclear
export of Rev and U snRNAs (Stutz et al., 1996), presum- ing also dissociates importin b from the NPC and in vitro
from individual nucleoporins (Rexach and Blobel, 1995;ably by titrating a factor required for their export. This
factor could be CRM1 (see below). GoÈ rlich et al., 1996a; Weis et al., 1996). In addition, GTP
hydrolysis by Ran is required for NLS protein importOf particular interest here is the fact that FG repeats
from CAN/Nup214 were among those that showed posi- (Melchior et al., 1993; Moore and Blobel, 1993; GoÈ rlich
et al., 1996a; Palacios et al., 1996; Weis et al., 1996).tive interaction with the Rev NES in the two-hybrid
assay. A significant fraction of hCRM1 exists in a com- Ignoring these latter additional functions of RanGTP,
two possible roles for the Ran asymmetry inexport couldplex with the nucleoporin CAN/Nup214, and this interac-
tion involves the FG repeat region (Fornerod et al., 1996). have been proposed. In the first, RanGDP in the cyto-
plasm might have bound to an export receptor andIt seems possible that human Rip/Rab is a nucleoporin,
and there is good evidence that yeast Rip is one (Fritz caused cargo release. In the second (Figure 7, bottom),
RanGTP would again be the active form of the GTPaseet al., 1995; Stutz et al., 1995; F. Stutz and M. Rosbash,
personal communication). One possibility is therefore but in this case would act to enable complex formation
between export cargo and an export receptor in thethat the two-hybrid interaction seen, and conceivably
also the interaction observed between Rab and Rev in nucleus. The complex would be dissociated by cyto-
plasmic GTP hydrolysis. Our data strongly suggest thatreticulocyte lysate, may have been indirect and medi-
ated by CRM1. CRM1-mediated NES protein export reflects aspects of
this latter model, with complex formation occurring onlyIf we model the function of CRM1 on what is known
about importin b and transportin, it is likely that CRM1 in the presence of cargo and RanGTP. The model pre-
sented inFigure 7 may begenerally applicable tonucleartranslocates through the NPC bound to the NES. This
might preclude direct NES-nucleoporin interaction, but export processes that require Ran and involve cargo.
In support of this, reducing the RanGTP concentrationit is conceivable that CRM1 hands off the NES to one
or more FG repeat-containing nucleoporins, for exam- in the nucleus has recently been shown to block export
of both NES proteins (Richards et al., 1997) and of multi-ple, at the end of the translocation process, and that
both the interaction with CRM1 and with the nucleoporin ple other export substrates (E. Izaurralde et al., submit-
ted). A variant of this model is represented by the recy-are direct. It is also possible that Rip/Rab and CRM1
would cooperatively interact with the NES. Our attempts cling of import receptors like importin b (GoÈ rlich et al.,
1997; Kutay et al., 1997). In this case, RanGTP bindingto detect an influence of the FG repeats on formation
of the CRM1/NES-containing complex have, however, to the receptor would form an export complex and would
not require the simultaneous presence of export cargo.been unsuccessful thus far.
CRM1 is a member of a family of proteins related to
importin b (Fornerod et al., 1997; GoÈ rlich et al., 1997) of
The Ran Asymmetry and Models which several had been shown to be mediators of nu-
for Directional Transport clear protein import (see Introduction). CRM1 in contrast
In order to see NES- and CRM1-containing complexes, appears to have a specific role in nuclear export, and a
it was necessary to add RanGTP, which itself was incor- second family member has been identified as the media-
porated into the complex. Conversely, RanGTP binding tor of recycling (reexport) of importin a from the nucleus
to CRM1 was detected only in the presence of NES (Kutay et al., [this issue of Cell]). As the names of these
peptides. This complex therefore assembles coopera- family members are mainly descriptive reflections of the
tively (Figure 7, bottom left).RanGTP-dependent assem- phenotypes they caused when first studied, a system-
bly is likely to have general significance for nuclear ex- atic nomenclature might be appropriate, and we pro-
pose the name ªexportinsº for those involved in nuclearport, based on the following arguments.
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supernatants were collected, and beads were washed once withexport. In the future, we will therefore refer to CRM1 as
100 ml B buffer containing the same supplements as during binding.exportin 1.
Equal fractions of supernatants and beads were analyzed by 6%
SDS-PAGE and fluorography.
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